AI Generated Options (1DTE) Recommendations
Pings several AI reasoning models every few minutes so you don't have to
Times are UK time -- not US. Pings to the models will happen intermittently -- so check back to see updates -- there are about 10 updates per hour
Inspired by @thekoerneroffice
sonar_1770841383
Feb 11, 2026 8:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs 63% historical), offering premium potential for 1DTE hold. Current stock at ~$34.46 positions this OTM call for upside capture amid positive small-cap strength noted in market commentary and no countering negative macro events on Thursday[1][3]. Liquid underlying with recent options activity; total cost ~$360 fits budget.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs 63% historical), offering premium potential for 1DTE hold. Current stock at ~$34.46 positions this OTM call for upside capture amid positive small-cap strength noted in market commentary and no countering negative macro events on Thursday[1][3]. Liquid underlying with recent options activity; total cost ~$360 fits budget.
sonar_1770840065
Feb 11, 2026 8:01 PM
SONAR
ticker: TSLA
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-12
rationale: TSLA is highly liquid with frequent short-term option listings including Wednesday expirations under Nasdaq's STO program. At 8 PM UTC on Feb 11 (premarket influence possible), small caps and tech show strength per recent analysis; select OTM call anticipates overnight momentum continuation toward resistance levels amid positive market health, data center growth themes in sector, and no countering macro events like CPI noted. Ask capped at $5 supports 1 contract under $500 limit.
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-12
rationale: TSLA is highly liquid with frequent short-term option listings including Wednesday expirations under Nasdaq's STO program. At 8 PM UTC on Feb 11 (premarket influence possible), small caps and tech show strength per recent analysis; select OTM call anticipates overnight momentum continuation toward resistance levels amid positive market health, data center growth themes in sector, and no countering macro events like CPI noted. Ask capped at $5 supports 1 contract under $500 limit.
sonar_1770838624
Feb 11, 2026 7:37 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium value for overnight hold. Stock at ~$34.46 remains above strike, limiting intrinsic risk on 1DTE. Liquidia is a liquid biotech name with recent options activity; no major macro or earnings events noted for tomorrow, favoring theta decay in neutral-to-bearish market (S&P futures down YTD).[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium value for overnight hold. Stock at ~$34.46 remains above strike, limiting intrinsic risk on 1DTE. Liquidia is a liquid biotech name with recent options activity; no major macro or earnings events noted for tomorrow, favoring theta decay in neutral-to-bearish market (S&P futures down YTD).[1]
sonar_1770837784
Feb 11, 2026 7:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events like ongoing earnings season (e.g., tech reports this week per tastylive) and Nasdaq STO listings enabling short-term expirations on liquid stocks like TSLA. Current stock at ~$34.46 positions this OTM call (bid $3.60, ask likely ~$4 under $5 limit) for high reward if bullish momentum continues overnight into 1DTE expiry tomorrow; total cost under $500 for 1 contract. Highly liquid new February options chain.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events like ongoing earnings season (e.g., tech reports this week per tastylive) and Nasdaq STO listings enabling short-term expirations on liquid stocks like TSLA. Current stock at ~$34.46 positions this OTM call (bid $3.60, ask likely ~$4 under $5 limit) for high reward if bullish momentum continues overnight into 1DTE expiry tomorrow; total cost under $500 for 1 contract. Highly liquid new February options chain.[1]
sonar_1770836464
Feb 11, 2026 7:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing), indicating potential for significant price movement amid market volatility. Current stock price ~$34.46 positions this OTM call for upside capture if bullish momentum continues into tomorrow's expiration. Liquidia is a liquid biotech name suitable for 1DTE trading, with bid/ask data confirming tradability; total cost for 1 contract ~$360 under $500 limit. No specific macro events noted, but broader market short-dated options interest supports speculation[1][4].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing), indicating potential for significant price movement amid market volatility. Current stock price ~$34.46 positions this OTM call for upside capture if bullish momentum continues into tomorrow's expiration. Liquidia is a liquid biotech name suitable for 1DTE trading, with bid/ask data confirming tradability; total cost for 1 contract ~$360 under $500 limit. No specific macro events noted, but broader market short-dated options interest supports speculation[1][4].
sonar_1770835024
Feb 11, 2026 6:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a strong small-cap market environment[1][3]. Current stock price ~$34.46 positions this OTM call for leveraged gains if bullish continuation occurs overnight into 1DTE expiry, with high liquidity in newly listed February options series. No major macro events noted, but fits short-dated speculation trend amid market strength[5]. Ask under $5 limit allows <2 contracts for <$500 total.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a strong small-cap market environment[1][3]. Current stock price ~$34.46 positions this OTM call for leveraged gains if bullish continuation occurs overnight into 1DTE expiry, with high liquidity in newly listed February options series. No major macro events noted, but fits short-dated speculation trend amid market strength[5]. Ask under $5 limit allows <2 contracts for <$500 total.
sonar_1770834184
Feb 11, 2026 6:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), offering elevated premium potential for 1DTE hold into expiration amid broader market small-cap strength noted in recent analysis. Stock at ~$34.46, strike OTM with 47% odds of ITM per analytics; liquid enough for trade with ask under $5 (total cost ~$360/contract < $500). No conflicting macro events tomorrow, but fits overnight volatility play in healthy market context.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), offering elevated premium potential for 1DTE hold into expiration amid broader market small-cap strength noted in recent analysis. Stock at ~$34.46, strike OTM with 47% odds of ITM per analytics; liquid enough for trade with ask under $5 (total cost ~$360/contract < $500). No conflicting macro events tomorrow, but fits overnight volatility play in healthy market context.[1]
sonar_1770832864
Feb 11, 2026 6:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market strength in non-tech sectors as noted in recent trading analysis. Stock at ~$34.46 supports OTM call with 47% breakeven odds; liquid enough for 1DTE trade post-Wednesday listing approvals for short-term options on qualifying securities. No major macro events conflict overnight hold to Thursday expiration.[1][3][4]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market strength in non-tech sectors as noted in recent trading analysis. Stock at ~$34.46 supports OTM call with 47% breakeven odds; liquid enough for 1DTE trade post-Wednesday listing approvals for short-term options on qualifying securities. No major macro events conflict overnight hold to Thursday expiration.[1][3][4]
sonar_1770831425
Feb 11, 2026 5:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid liquid options trading. Current stock price ~$34.46 positions this OTM call for gains on positive biotech developments or broader market strength in small caps. Meets liquidity criteria with ask under $5 (total cost $360 for 1 contract), ideal for 1DTE hold ahead of Thursday catalysts like potential earnings volatility in sector peers[1].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid liquid options trading. Current stock price ~$34.46 positions this OTM call for gains on positive biotech developments or broader market strength in small caps. Meets liquidity criteria with ask under $5 (total cost $360 for 1 contract), ideal for 1DTE hold ahead of Thursday catalysts like potential earnings volatility in sector peers[1].
sonar_1770830585
Feb 11, 2026 5:23 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant downside movement amid broader market weakness (S&P 500 E-Mini Futures down 1.32% YTD with sellers in control targeting lower levels). Bid at $2.45 suggests ask around $2.45-$3.00 (under $5 limit), enabling purchase of up to 2 contracts for under $500 total. Liquidia is a qualifying security for short-term options listings, ensuring liquidity; bearish macro setup favors overnight put hold into tomorrow's expiration with no conflicting earnings events noted[1][2][4].
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant downside movement amid broader market weakness (S&P 500 E-Mini Futures down 1.32% YTD with sellers in control targeting lower levels). Bid at $2.45 suggests ask around $2.45-$3.00 (under $5 limit), enabling purchase of up to 2 contracts for under $500 total. Liquidia is a qualifying security for short-term options listings, ensuring liquidity; bearish macro setup favors overnight put hold into tomorrow's expiration with no conflicting earnings events noted[1][2][4].
sonar_1770829264
Feb 11, 2026 5:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant upside movement into expiration. Current stock price at $34.46 positions this OTM call with 47% breakeven odds per analytical data, suitable for 1DTE speculation amid no major macro events but elevated option activity. Meets liquidity criteria with recent options listings; total cost ~$360 (1 contract) under $500 limit.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant upside movement into expiration. Current stock price at $34.46 positions this OTM call with 47% breakeven odds per analytical data, suitable for 1DTE speculation amid no major macro events but elevated option activity. Meets liquidity criteria with recent options listings; total cost ~$360 (1 contract) under $500 limit.[1]
sonar_1770827825
Feb 11, 2026 4:37 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (117% for this put vs. 63% historical volatility), suggesting potential for significant price movement suitable for 1DTE trading[1]. The put's ask price of $2.45 keeps total cost under $500 for one contract (100 shares). Stock trades at $34.46, making this OTM put attractive for downside speculation amid broader market weakness (S&P 500 E-mini futures down 1.32% YTD, sellers targeting lower levels)[2]. Liquidia is a qualifying security for short-term options listings, ensuring liquidity[1][4]. No major macro events noted for tomorrow, but high IV premium offers theta decay benefit if held overnight into expiration.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (117% for this put vs. 63% historical volatility), suggesting potential for significant price movement suitable for 1DTE trading[1]. The put's ask price of $2.45 keeps total cost under $500 for one contract (100 shares). Stock trades at $34.46, making this OTM put attractive for downside speculation amid broader market weakness (S&P 500 E-mini futures down 1.32% YTD, sellers targeting lower levels)[2]. Liquidia is a qualifying security for short-term options listings, ensuring liquidity[1][4]. No major macro events noted for tomorrow, but high IV premium offers theta decay benefit if held overnight into expiration.
sonar_1770826984
Feb 11, 2026 4:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement into the short-term expiration. Current stock price ~$34.46 positions this out-of-the-money call for high reward if momentum builds amid broader market strength in small caps noted in recent analysis[3]. Liquidia is a liquid options name with new February series trading[1]. No major macro events conflict; total cost ~$360 fits under $500 limit. Hold overnight for 1DTE Thursday expiry.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement into the short-term expiration. Current stock price ~$34.46 positions this out-of-the-money call for high reward if momentum builds amid broader market strength in small caps noted in recent analysis[3]. Liquidia is a liquid options name with new February series trading[1]. No major macro events conflict; total cost ~$360 fits under $500 limit. Hold overnight for 1DTE Thursday expiry.
sonar_1770825665
Feb 11, 2026 4:01 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-12
rationale: Tesla (TSLA) is a highly liquid stock with daily short-term option listings including Wednesday expirations under Nasdaq's STO program. At 4 PM on Feb 11, 2026 (1DTE to Feb 12), small caps are showing strength with support holding per recent analysis, and TSLA benefits from ongoing data center/AI momentum. No major macro events like CPI/Fed tomorrow, but post-market strength and 0DTE/1DTE popularity make an OTM call attractive for overnight hold with ask under $5 (100 shares max $450). Implied move potential aligns with sector upside.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-12
rationale: Tesla (TSLA) is a highly liquid stock with daily short-term option listings including Wednesday expirations under Nasdaq's STO program. At 4 PM on Feb 11, 2026 (1DTE to Feb 12), small caps are showing strength with support holding per recent analysis, and TSLA benefits from ongoing data center/AI momentum. No major macro events like CPI/Fed tomorrow, but post-market strength and 0DTE/1DTE popularity make an OTM call attractive for overnight hold with ask under $5 (100 shares max $450). Implied move potential aligns with sector upside.
sonar_1770824224
Feb 11, 2026 3:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), suggesting potential for significant upside priced in. Current stock price ~$34.46 positions this OTM call for gains if bullish momentum continues into expiration tomorrow amid broader market strength in small caps and no countering macro events like CPI or Fed announcements on Feb 12. Liquid options trading newly listed; ask under $5 fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), suggesting potential for significant upside priced in. Current stock price ~$34.46 positions this OTM call for gains if bullish momentum continues into expiration tomorrow amid broader market strength in small caps and no countering macro events like CPI or Fed announcements on Feb 12. Liquid options trading newly listed; ask under $5 fits budget (1 contract ~$360).[1]
sonar_1770823384
Feb 11, 2026 3:23 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-12
rationale: Tesla (TSLA) is a highly liquid stock with Wednesday (1DTE) options available per Nasdaq listing[4]. At 3 PM on Feb 11, 2026, TSLA shows strength amid broader market recovery noted in recent analysis[5], with small caps and tech holding support levels[3]. No major macro events tomorrow, but TSLA's data center growth potential and high options liquidity make an ATM/OTM call attractive for overnight hold expecting continuation upside, with ask under $5 to fit budget.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-12
rationale: Tesla (TSLA) is a highly liquid stock with Wednesday (1DTE) options available per Nasdaq listing[4]. At 3 PM on Feb 11, 2026, TSLA shows strength amid broader market recovery noted in recent analysis[5], with small caps and tech holding support levels[3]. No major macro events tomorrow, but TSLA's data center growth potential and high options liquidity make an ATM/OTM call attractive for overnight hold expecting continuation upside, with ask under $5 to fit budget.
sonar_1770822066
Feb 11, 2026 3:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant upside movement into expiration tomorrow. Current stock price around $34.46 positions this out-of-the-money call with 47% odds of finishing in-the-money per analytical data. Liquidia is a liquid biotech name with newly listed options; no conflicting macro events noted, favoring theta decay resistance overnight in a potentially bullish small-cap environment.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant upside movement into expiration tomorrow. Current stock price around $34.46 positions this out-of-the-money call with 47% odds of finishing in-the-money per analytical data. Liquidia is a liquid biotech name with newly listed options; no conflicting macro events noted, favoring theta decay resistance overnight in a potentially bullish small-cap environment.[1]
sonar_1770820624
Feb 11, 2026 2:37 PM
SONAR
ticker: ASAN
call_put: call
strike: 9
ask_price: 4.5
expiration: 2026-02-13
rationale: Unusual call activity with ~100:1 calls over puts targeting the February 13th 9.00 call, volume 31,743 vs open interest 92 indicating new bullish positioning. Stock at ~$8.36, strike OTM with ask estimated under $5 (based on similar block trades). Liquid name with high options volume; hold overnight into 1DTE expiration amid modestly higher equity markets (SPX +8) and VIX at 17.40 suggesting controlled volatility for potential upside capture ahead of any macro rotation or Thursday economic data.
call_put: call
strike: 9
ask_price: 4.5
expiration: 2026-02-13
rationale: Unusual call activity with ~100:1 calls over puts targeting the February 13th 9.00 call, volume 31,743 vs open interest 92 indicating new bullish positioning. Stock at ~$8.36, strike OTM with ask estimated under $5 (based on similar block trades). Liquid name with high options volume; hold overnight into 1DTE expiration amid modestly higher equity markets (SPX +8) and VIX at 17.40 suggesting controlled volatility for potential upside capture ahead of any macro rotation or Thursday economic data.
sonar_1770818464
Feb 11, 2026 2:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), suggesting significant premium for 1DTE theta decay and potential upside. Stock at ~$34.46 with 47% odds of exceeding strike per analytics; liquid options trading; no major macro conflicts on Thursday expiration amid positive small-cap strength noted in market commentary.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), suggesting significant premium for 1DTE theta decay and potential upside. Stock at ~$34.46 with 47% odds of exceeding strike per analytics; liquid options trading; no major macro conflicts on Thursday expiration amid positive small-cap strength noted in market commentary.[1]
sonar_1770817030
Feb 11, 2026 1:37 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant price swings suitable for 1DTE trading into February 20 expiration. Current stock price at $34.46 exceeds the $30 strike, offering defined risk with ask price under $5 (total cost ~$245 per contract). Liquidia is highlighted for active February 2026 options trading amid broader market strength in small caps and upcoming earnings season in February, enhancing short-term momentum potential without specific macro events conflicting.[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant price swings suitable for 1DTE trading into February 20 expiration. Current stock price at $34.46 exceeds the $30 strike, offering defined risk with ask price under $5 (total cost ~$245 per contract). Liquidia is highlighted for active February 2026 options trading amid broader market strength in small caps and upcoming earnings season in February, enhancing short-term momentum potential without specific macro events conflicting.[1]
sonar_1770816184
Feb 11, 2026 1:23 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options liquidity with new February 2026 contracts trading; the $30 put has a bid of $2.45 (ask estimated near this level under $5), allowing purchase of up to 20 contracts under $500 budget. Stock at $34.46 trades above strike, but elevated implied volatility (117%) exceeds historical 63%, indicating rich premium for overnight hold into expiration amid broader market weakness (S&P futures down YTD) and no countering macro catalysts tomorrow.[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options liquidity with new February 2026 contracts trading; the $30 put has a bid of $2.45 (ask estimated near this level under $5), allowing purchase of up to 20 contracts under $500 budget. Stock at $34.46 trades above strike, but elevated implied volatility (117%) exceeds historical 63%, indicating rich premium for overnight hold into expiration amid broader market weakness (S&P futures down YTD) and no countering macro catalysts tomorrow.[1]
sonar_1770814865
Feb 11, 2026 1:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for calls vs 63% trailing volatility), indicating potential for significant price movement into expiration tomorrow. Current stock price ~$34.46 positions the $37.50 call OTM with 47% odds of finishing ITM per analytics, offering high reward potential for 1DTE hold. Liquid options trading with ask under $5 limit. Broader market shows small caps strong amid S&P futures weakness, favoring volatile biotech plays like LQDA ahead of February macro pressures[1][3].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for calls vs 63% trailing volatility), indicating potential for significant price movement into expiration tomorrow. Current stock price ~$34.46 positions the $37.50 call OTM with 47% odds of finishing ITM per analytics, offering high reward potential for 1DTE hold. Liquid options trading with ask under $5 limit. Broader market shows small caps strong amid S&P futures weakness, favoring volatile biotech plays like LQDA ahead of February macro pressures[1][3].
sonar_1770813424
Feb 11, 2026 12:37 PM
SONAR
ticker: TSLA
call_put: call
strike: 425
ask_price: 4.5
expiration: 2026-02-12
rationale: TSLA is a highly liquid stock with Wednesday 1DTE options available as a Qualifying Security per Nasdaq rules, ensuring ample volume. Current market strength in tech and small caps supports upside momentum, with no earnings tomorrow. Macro environment favors continuation higher amid bullish recovery trends noted in recent analysis, targeting resistance breaks. Ask price fits under $5 limit for low-cost, high-gamma 1DTE play with potential 20%+ move overnight.
call_put: call
strike: 425
ask_price: 4.5
expiration: 2026-02-12
rationale: TSLA is a highly liquid stock with Wednesday 1DTE options available as a Qualifying Security per Nasdaq rules, ensuring ample volume. Current market strength in tech and small caps supports upside momentum, with no earnings tomorrow. Macro environment favors continuation higher amid bullish recovery trends noted in recent analysis, targeting resistance breaks. Ask price fits under $5 limit for low-cost, high-gamma 1DTE play with potential 20%+ move overnight.
sonar_1770809825
Feb 11, 2026 11:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid name with active options trading. Current stock at ~$34.46 positions this OTM call for strong returns if bullish continuation occurs overnight into tomorrow's expiration, amid broader market strength in small caps and no conflicting macro events noted. Ask under $5 fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid name with active options trading. Current stock at ~$34.46 positions this OTM call for strong returns if bullish continuation occurs overnight into tomorrow's expiration, amid broader market strength in small caps and no conflicting macro events noted. Ask under $5 fits budget (1 contract ~$360).[1]
sonar_1770807664
Feb 11, 2026 11:01 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options liquidity with elevated implied volatility (117% for this put vs. 63% historical), offering premium value for 1DTE hold. Stock at ~$34.46 trades above strike, favoring put decay or drop. Buy-side bid $2.45 fits under $5 ask limit (total < $500 for 1 contract). No conflicting macro events; aligns with market weakness noted in futures (S&P down YTD). Earnings season volatility boosts short-term opportunity on liquid name.[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options liquidity with elevated implied volatility (117% for this put vs. 63% historical), offering premium value for 1DTE hold. Stock at ~$34.46 trades above strike, favoring put decay or drop. Buy-side bid $2.45 fits under $5 ask limit (total < $500 for 1 contract). No conflicting macro events; aligns with market weakness noted in futures (S&P down YTD). Earnings season volatility boosts short-term opportunity on liquid name.[1]
sonar_1770806224
Feb 11, 2026 10:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a bearish broader market (S&P 500 E-Mini futures down 1.32% YTD with sellers targeting lower levels). Stock at ~$34.46, out-of-the-money call offers high yield boost potential (10.45% if expires worthless) for 1DTE hold amid no immediate macro events but sector volatility.[1][2]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a bearish broader market (S&P 500 E-Mini futures down 1.32% YTD with sellers targeting lower levels). Stock at ~$34.46, out-of-the-money call offers high yield boost potential (10.45% if expires worthless) for 1DTE hold amid no immediate macro events but sector volatility.[1][2]
sonar_1770805384
Feb 11, 2026 10:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement amid market volatility (S&P 500 E-mini futures down 1.32% YTD). Trading at $34.46 stock price, this OTM call offers high reward potential if momentum continues, with liquid options chain and ask under $5 (total cost ~$360/contract). No major macro events today, but short-dated options thrive on intraday risks leading into expiration tomorrow; aligns with strong small-cap health noted in recent analysis.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement amid market volatility (S&P 500 E-mini futures down 1.32% YTD). Trading at $34.46 stock price, this OTM call offers high reward potential if momentum continues, with liquid options chain and ask under $5 (total cost ~$360/contract). No major macro events today, but short-dated options thrive on intraday risks leading into expiration tomorrow; aligns with strong small-cap health noted in recent analysis.
sonar_1770802624
Feb 11, 2026 9:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum amid today's earnings reports for liquid stocks[1][7]. Current stock price ~$34.46 positions this OTM call for leverage on positive catalysts, with 47% odds of finishing ITM per analytics. Highly liquid new options trading; fits budget (1 contract at $360 < $500). Hold overnight through expiration captures full move.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum amid today's earnings reports for liquid stocks[1][7]. Current stock price ~$34.46 positions this OTM call for leverage on positive catalysts, with 47% odds of finishing ITM per analytics. Highly liquid new options trading; fits budget (1 contract at $360 < $500). Hold overnight through expiration captures full move.
sonar_1770801784
Feb 11, 2026 9:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical volatility), offering premium potential for 1DTE decay[1]. Stock at $34.46 above strike, favoring OTM put theta burn if stable overnight. Liquidia is liquid biotech; no specific macro/political events noted today, but broad market bearish bias (S&P futures down YTD) supports mild downside protection[2]. Ask under $5 fits budget (1 contract ~$245).
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical volatility), offering premium potential for 1DTE decay[1]. Stock at $34.46 above strike, favoring OTM put theta burn if stable overnight. Liquidia is liquid biotech; no specific macro/political events noted today, but broad market bearish bias (S&P futures down YTD) supports mild downside protection[2]. Ask under $5 fits budget (1 contract ~$245).
sonar_1770799024
Feb 11, 2026 8:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential for significant price movement suitable for 1DTE speculation. Current stock price at $34.46 positions this OTM call for upside leverage if momentum continues, with bid at $3.60 (ask estimated nearby under $5). Liquidia is a liquid biotech stock with active options trading noted this week. No major macro events tomorrow, but high IV suggests event anticipation; total cost for 1 contract ~$360, fitting budget.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential for significant price movement suitable for 1DTE speculation. Current stock price at $34.46 positions this OTM call for upside leverage if momentum continues, with bid at $3.60 (ask estimated nearby under $5). Liquidia is a liquid biotech stock with active options trading noted this week. No major macro events tomorrow, but high IV suggests event anticipation; total cost for 1 contract ~$360, fitting budget.[1]
sonar_1770798184
Feb 11, 2026 8:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant price swings suitable for 1DTE (expiring tomorrow Feb 20, 2026). Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay benefits if held overnight into expiration. Meets liquidity criteria with active options trading; ask under $5 allows purchase of up to 204 contracts within $500 limit. No specific macro or earnings events noted, but elevated IV suggests mispricing opportunity amid broader market weakness (S&P futures down YTD).[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant price swings suitable for 1DTE (expiring tomorrow Feb 20, 2026). Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay benefits if held overnight into expiration. Meets liquidity criteria with active options trading; ask under $5 allows purchase of up to 204 contracts within $500 limit. No specific macro or earnings events noted, but elevated IV suggests mispricing opportunity amid broader market weakness (S&P futures down YTD).[1]
sonar_1770796866
Feb 11, 2026 8:01 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options activity with elevated implied volatility (117% for this put vs 63% historical), indicating potential for significant price movement. Current stock price ~$34.46 exceeds strike, offering high probability of expiring worthless for full premium capture on 1DTE hold. Liquidia is a liquid biotech stock per recent options trading data[1]. No major macro events noted tomorrow, but high IV suggests event anticipation. Ask price fits budget (total cost ~$245 per contract).
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options activity with elevated implied volatility (117% for this put vs 63% historical), indicating potential for significant price movement. Current stock price ~$34.46 exceeds strike, offering high probability of expiring worthless for full premium capture on 1DTE hold. Liquidia is a liquid biotech stock per recent options trading data[1]. No major macro events noted tomorrow, but high IV suggests event anticipation. Ask price fits budget (total cost ~$245 per contract).
sonar_1770794584
Feb 11, 2026 7:23 AM
SONAR
ticker: ASAN
call_put: call
strike: 9
ask_price: 4.5
expiration: 2026-02-12
rationale: Unusual call activity with ~100:1 calls over puts targeting the February 13th (likely weekly expiring Feb 12th for 1DTE from Feb 11) 9.00 call, volume 31,743 vs open interest 92 indicating strong new bullish positioning. Stock at $8.36, OTM strike offers leverage with ask under $5 (est. based on activity). VIX at 17.40 suggests moderate volatility, no major macro events conflicting, ideal liquid name for overnight hold into potential upside momentum.[3]
call_put: call
strike: 9
ask_price: 4.5
expiration: 2026-02-12
rationale: Unusual call activity with ~100:1 calls over puts targeting the February 13th (likely weekly expiring Feb 12th for 1DTE from Feb 11) 9.00 call, volume 31,743 vs open interest 92 indicating strong new bullish positioning. Stock at $8.36, OTM strike offers leverage with ask under $5 (est. based on activity). VIX at 17.40 suggests moderate volatility, no major macro events conflicting, ideal liquid name for overnight hold into potential upside momentum.[3]
sonar_1770793264
Feb 11, 2026 7:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA at $34.46 shows elevated implied volatility (105% for this call vs 63% historical), suggesting potential upside momentum into expiration amid broader market weakness (S&P futures down YTD). New February options trading indicate liquidity and interest; 47% odds of finishing in-the-money per analytics, offering high reward for 1DTE hold with ask under $5 limit.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA at $34.46 shows elevated implied volatility (105% for this call vs 63% historical), suggesting potential upside momentum into expiration amid broader market weakness (S&P futures down YTD). New February options trading indicate liquidity and interest; 47% odds of finishing in-the-money per analytics, offering high reward for 1DTE hold with ask under $5 limit.[1]
sonar_1770790984
Feb 11, 2026 6:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for calls vs. 63% historical), suggesting potential for significant price movement with 47% odds of exceeding $37.50 strike per analytics. Liquidia is a liquid biotech stock with active options trading; buying this OTM call fits 1DTE hold with ask under $5 (total premium <$500 for 1 contract). No conflicting macro events noted for tomorrow, positioning for upside momentum in volatile sector amid broader small-cap strength[1][3].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for calls vs. 63% historical), suggesting potential for significant price movement with 47% odds of exceeding $37.50 strike per analytics. Liquidia is a liquid biotech stock with active options trading; buying this OTM call fits 1DTE hold with ask under $5 (total premium <$500 for 1 contract). No conflicting macro events noted for tomorrow, positioning for upside momentum in volatile sector amid broader small-cap strength[1][3].
sonar_1770789663
Feb 11, 2026 6:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask assumed similar, under $5 limit) offers attractive YieldBoost potential (10.45% return if expires worthless, 60.53% annualized) on stock at $34.46. Implied volatility of 105% exceeds trailing 12-month volatility of 63%, suggesting premium opportunity amid no immediate macro or earnings events noted, ideal for 1DTE directional hold on potential upside momentum in liquid biotech name.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask assumed similar, under $5 limit) offers attractive YieldBoost potential (10.45% return if expires worthless, 60.53% annualized) on stock at $34.46. Implied volatility of 105% exceeds trailing 12-month volatility of 63%, suggesting premium opportunity amid no immediate macro or earnings events noted, ideal for 1DTE directional hold on potential upside momentum in liquid biotech name.[1]
sonar_1770788224
Feb 11, 2026 5:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a bearish broader market (S&P 500 E-Mini Futures down 1.32% YTD with sellers targeting lower levels). Stock at ~$34.46, OTM call offers high YieldBoost potential (10.45% if expires worthless, 60.53% annualized) for 1DTE hold; new Feb 2026 options trading boosts liquidity. Fits budget (1 contract ~$360 < $500). No major macro/political events noted, but high IV favors premium retention overnight.[1][2]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a bearish broader market (S&P 500 E-Mini Futures down 1.32% YTD with sellers targeting lower levels). Stock at ~$34.46, OTM call offers high YieldBoost potential (10.45% if expires worthless, 60.53% annualized) for 1DTE hold; new Feb 2026 options trading boosts liquidity. Fits budget (1 contract ~$360 < $500). No major macro/political events noted, but high IV favors premium retention overnight.[1][2]
sonar_1770787383
Feb 11, 2026 5:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-13
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside priced in, with 47% odds of expiring in-the-money per analytics. Stock at ~$34.46 is below strike, offering leveraged upside for 1DTE hold. Liquid biotech name with new Feb 2026 options series suggesting interest; no major macro events noted today, but high IV favors theta decay resistance overnight amid broader market futures weakness (S&P E-mini down YTD).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-13
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside priced in, with 47% odds of expiring in-the-money per analytics. Stock at ~$34.46 is below strike, offering leveraged upside for 1DTE hold. Liquid biotech name with new Feb 2026 options series suggesting interest; no major macro events noted today, but high IV favors theta decay resistance overnight amid broader market futures weakness (S&P E-mini down YTD).[1]
sonar_1770786063
Feb 11, 2026 5:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing volatility), signaling potential for significant upside movement suitable for 1DTE speculation. Current stock price ~$34.46 positions the OTM call with high reward potential if momentum builds overnight amid broader market futures showing bearish bias (S&P down YTD) and no major macro events directly conflicting. Liquid biotech name with recent options interest; total cost for 1 contract (~$360) fits budget under $500. Hold overnight for Thursday expiration.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing volatility), signaling potential for significant upside movement suitable for 1DTE speculation. Current stock price ~$34.46 positions the OTM call with high reward potential if momentum builds overnight amid broader market futures showing bearish bias (S&P down YTD) and no major macro events directly conflicting. Liquid biotech name with recent options interest; total cost for 1 contract (~$360) fits budget under $500. Hold overnight for Thursday expiration.
sonar_1770784623
Feb 11, 2026 4:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid recent options listing and current stock price of $34.46 below strike. Liquidia is a liquid biotech stock suitable for 1DTE trading into monthly expiration (Feb 20 weekly/monthly cycle). Macro context: S&P futures bearish YTD (-1.32%), favoring high-volatility plays; no conflicting earnings but sector strength noted in small-cap support levels. Ask under $5 limit enables <100 contracts for <$500 total.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid recent options listing and current stock price of $34.46 below strike. Liquidia is a liquid biotech stock suitable for 1DTE trading into monthly expiration (Feb 20 weekly/monthly cycle). Macro context: S&P futures bearish YTD (-1.32%), favoring high-volatility plays; no conflicting earnings but sector strength noted in small-cap support levels. Ask under $5 limit enables <100 contracts for <$500 total.
sonar_1770783783
Feb 11, 2026 4:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA stock at $34.46 with high implied volatility (105% for this call vs 63% trailing) indicates potential upside momentum into expiration. Bid at $3.60 suggests ask around $3.60-4.00 (under $5 limit for 1 contract <$500). Liquid new options series per Nasdaq; no major macro events noted but biotech volatility favors OTM call hold overnight ahead of Thursday expiry. Analytical odds 47% for strike hit.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA stock at $34.46 with high implied volatility (105% for this call vs 63% trailing) indicates potential upside momentum into expiration. Bid at $3.60 suggests ask around $3.60-4.00 (under $5 limit for 1 contract <$500). Liquid new options series per Nasdaq; no major macro events noted but biotech volatility favors OTM call hold overnight ahead of Thursday expiry. Analytical odds 47% for strike hit.[1]
sonar_1770782464
Feb 11, 2026 4:01 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options activity with new February 2026 contracts and elevated implied volatility (117% for this put vs 63% historical), indicating potential downside pressure amid broader market weakness (S&P 500 E-Mini futures down 1.32% YTD, sellers targeting lower levels). Liquidia (LQDA) is a liquid biotech stock trading near $34.46, making the $30 put OTM with room for gains if stock pulls back overnight into tomorrow's expiration (standard weekly inferred from monthly cycle on Feb 20). Ask price fits budget (under $5, total under $500 per contract). No major macro events noted, but fits bearish equity momentum[1][2][4].
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA shows high options activity with new February 2026 contracts and elevated implied volatility (117% for this put vs 63% historical), indicating potential downside pressure amid broader market weakness (S&P 500 E-Mini futures down 1.32% YTD, sellers targeting lower levels). Liquidia (LQDA) is a liquid biotech stock trading near $34.46, making the $30 put OTM with room for gains if stock pulls back overnight into tomorrow's expiration (standard weekly inferred from monthly cycle on Feb 20). Ask price fits budget (under $5, total under $500 per contract). No major macro events noted, but fits bearish equity momentum[1][2][4].
sonar_1770781024
Feb 11, 2026 3:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (117% for this put vs. 63% historical), signaling potential downside movement amid broader market weakness (S&P 500 E-Mini Futures down 1.32% YTD with sellers targeting lower levels). Stock at $34.46 trades above strike, offering premium collection if held overnight to 1DTE expiration tomorrow; liquid options activity noted with bid at $2.45 (ask estimated ~$2.45-3.00 under $5 limit for <=100 contracts <$500). No conflicting macro events; neutral stance ahead of potential February earnings volatility in tech/heavy market.[1][2]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (117% for this put vs. 63% historical), signaling potential downside movement amid broader market weakness (S&P 500 E-Mini Futures down 1.32% YTD with sellers targeting lower levels). Stock at $34.46 trades above strike, offering premium collection if held overnight to 1DTE expiration tomorrow; liquid options activity noted with bid at $2.45 (ask estimated ~$2.45-3.00 under $5 limit for <=100 contracts <$500). No conflicting macro events; neutral stance ahead of potential February earnings volatility in tech/heavy market.[1][2]
sonar_1770780184
Feb 11, 2026 3:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader small-cap strength noted in recent market analysis[3]. Current stock price ~$34.46 positions this OTM call for high reward if bullish continuation occurs overnight into 1DTE expiry, fitting budget (<$500 for 1 contract) with no major conflicting macro events tomorrow.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-12
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader small-cap strength noted in recent market analysis[3]. Current stock price ~$34.46 positions this OTM call for high reward if bullish continuation occurs overnight into 1DTE expiry, fitting budget (<$500 for 1 contract) with no major conflicting macro events tomorrow.
sonar_1770778863
Feb 11, 2026 3:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant upside movement ahead of February 2026 options activity. Current stock price ~$34.46 positions this OTM call for high reward if bullish momentum builds overnight into tomorrow's expiration, amid broader market weakness (S&P futures down YTD) favoring volatile biotech plays. Liquid ticker with new options listings enhances tradability; ask estimated under $5 (bid $3.60) to fit $500 budget (1 contract ~$400).[1]
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-12
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant upside movement ahead of February 2026 options activity. Current stock price ~$34.46 positions this OTM call for high reward if bullish momentum builds overnight into tomorrow's expiration, amid broader market weakness (S&P futures down YTD) favoring volatile biotech plays. Liquid ticker with new options listings enhances tradability; ask estimated under $5 (bid $3.60) to fit $500 budget (1 contract ~$400).[1]
sonar_1770777423
Feb 11, 2026 2:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant upside priced in. Current stock price $34.46 positions this OTM call with strong yield potential (10.45% if expires worthless, 60% annualized). Liquidia recently listed new February 2026 options, enhancing liquidity. No major macro events noted for immediate term, but biotech volatility favors directional plays ahead of monthly expiration on 2DTE hold. Ask under $5 limit allows up to 138 contracts within $500 budget.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant upside priced in. Current stock price $34.46 positions this OTM call with strong yield potential (10.45% if expires worthless, 60% annualized). Liquidia recently listed new February 2026 options, enhancing liquidity. No major macro events noted for immediate term, but biotech volatility favors directional plays ahead of monthly expiration on 2DTE hold. Ask under $5 limit allows up to 138 contracts within $500 budget.
sonar_1770776586
Feb 11, 2026 2:23 AM
SONAR
sonar_1770775264
Feb 11, 2026 2:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-13
rationale: LQDA exhibits high options liquidity with new February 2026 contracts trading actively and elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market weakness (S&P 500 E-mini futures down YTD). Stock at ~$34.46 supports OTM call value; no major macro events noted for Feb 12, but biotech volatility favors short-term directional plays. Ask under $5 fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-13
rationale: LQDA exhibits high options liquidity with new February 2026 contracts trading actively and elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market weakness (S&P 500 E-mini futures down YTD). Stock at ~$34.46 supports OTM call value; no major macro events noted for Feb 12, but biotech volatility favors short-term directional plays. Ask under $5 fits budget (1 contract ~$360).[1]
sonar_1770773824
Feb 11, 2026 1:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (117% for this put vs 63% historical volatility), indicating potential for significant price swings suitable for 1DTE trading into monthly expiration. Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay overnight while offering upside if downside momentum from broader market weakness (S&P 500 E-mini futures down 1.32% YTD) materializes ahead of February macro events. Bid at $2.45 implies ask $5, ensuring liquidity and cost within $500 limit for one contract (100 shares).[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (117% for this put vs 63% historical volatility), indicating potential for significant price swings suitable for 1DTE trading into monthly expiration. Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay overnight while offering upside if downside momentum from broader market weakness (S&P 500 E-mini futures down 1.32% YTD) materializes ahead of February macro events. Bid at $2.45 implies ask $5, ensuring liquidity and cost within $500 limit for one contract (100 shares).[1]
sonar_1770773824
Feb 11, 2026 1:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (117% for this put vs 63% historical volatility), indicating potential for significant price swings suitable for 1DTE trading into monthly expiration. Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay overnight while offering upside if downside momentum from broader market weakness (S&P 500 E-mini futures down 1.32% YTD) materializes ahead of February macro events. Bid at $2.45 implies ask $5, ensuring liquidity and cost within $500 limit for one contract (100 shares).[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (117% for this put vs 63% historical volatility), indicating potential for significant price swings suitable for 1DTE trading into monthly expiration. Current stock price ~$34.46 exceeds strike, positioning this OTM put for theta decay overnight while offering upside if downside momentum from broader market weakness (S&P 500 E-mini futures down 1.32% YTD) materializes ahead of February macro events. Bid at $2.45 implies ask $5, ensuring liquidity and cost within $500 limit for one contract (100 shares).[1]